DAWN R&D to Revenue
Day One Biopharmaceuticals Inc · R&D to Revenue
DAWN R&D to Revenue
Latest reported93.65%period ending
DAWN FY R&D/Revenue (0.00% → 93.65%)
Latest values, visible window
High-resolution chart · PNG
DAWN r&d to revenue history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D to Revenue |
|---|---|
| 93.6485% | |
| 173.605% | |
| 0% | |
| 0% | |
| 0% | |
| 0% | |
| 0% |